Xin Hua She·2025-10-25 10:40Core Viewpoint - Beijing has announced the planning scheme for the International Biomedical Innovation Park (BioPark), aiming to establish a global hub for pharmaceutical health innovation through high-standard industrial functional zones [1][2] Group 1: Industrial Functional Zones - The BioPark will feature four main industrial functional zones: Headquarters Gathering Area, Medical-Engineering Integration Area, R&D Transformation Area, and Pharmaceutical Intelligent Manufacturing Area [1] - The Headquarters Gathering Area will focus on becoming an international pharmaceutical industry exchange hub, attracting top global biopharmaceutical companies and innovation centers [1] - The Medical-Engineering Integration Area aims to introduce national-level research institutions and clinical research centers to support cross-innovation in medical and engineering fields [1] - The R&D Transformation Area will consolidate common technology service platforms, creating an integrated space from research and development to large-scale production [1] - The Pharmaceutical Intelligent Manufacturing Area will concentrate on smart manufacturing "lighthouse factories" to promote the industrialization of significant global innovations [1] Group 2: Infrastructure and Collaborations - The park will host a national artificial intelligence application pilot base and develop critical infrastructure such as a supercomputing base and a trusted data space for the healthcare and pharmaceutical industries [1] - Collaborations with renowned universities will lead to the establishment of a life and health industry integration base and the Beijing Life and Health Industry Innovation Research Institute [1] - An international clinical medicine research center will be built, focusing on medical research and innovation transformation [1] Group 3: Current Attractiveness - The BioPark is strategically located along Beijing's southern central axis and has already attracted multinational companies such as Eli Lilly, Pfizer, Bayer, and Medtronic, covering areas like innovative drugs and high-end medical devices [2]